Oxodipine

Oxodipine Struktur
90729-41-2
CAS-Nr.
90729-41-2
Englisch Name:
Oxodipine
Synonyma:
Oxodipine;5-O-ethyl 3-O-methyl 4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate;3,5-Pyridinedicarboxylic acid, 4-(1,3-benzodioxol-4-yl)-1,4-dihydro-2,6-dimethyl-, 3-ethyl 5-methyl ester
CBNumber:
CB71117045
Summenformel:
C19H21NO6
Molgewicht:
359.37
MOL-Datei:
90729-41-2.mol

Oxodipine Eigenschaften

Siedepunkt:
470.0±45.0 °C(Predicted)
Dichte
1.247±0.06 g/cm3(Predicted)
pka
2.98±0.70(Predicted)

Sicherheit

Oxodipine Chemische Eigenschaften,Einsatz,Produktion Methoden

Enzyminhibitor

This dihydropyridine-class calcium ion blocker (FW = 359.37 g/mol; CAS 90729-41-2), also known as 4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-1,4- dihydropyridine-3,5-dicarboxylic acid O3 -ethyl,O5 -methyl ester, greatly depresses KCl-induced contraction of rabbit aorta and also decreases the contractile force of rat ventricular strips, the latter with lower potency. Oxodipine markedly shortens cardiac action potentials, and, in rat cultured neonatal ventricular myocytes, oxodipine decreases the L-type Ca2+ current (ICaL) with IC50 of 0.24 μM and is also an effective blocker of T-type Ca2+ current (ICaT) than elgodipine (IC50 = 0.41 μM).

Oxodipine Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Oxodipine Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 4008200310
marketing@tsbiochem.com China 24017 58
Suzhou Zhixin Biotechnology Co., Ltd. 0512-65118909 15162312715
sales@szzxbio.com China 2992 58
Shaanxi Xihua Chemical Industry Co., Ltd 17691182729 15529505138
1021@dideu.com China 9966 58

  • Oxodipine
  • 5-O-ethyl 3-O-methyl 4-(1,3-benzodioxol-4-yl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
  • 3,5-Pyridinedicarboxylic acid, 4-(1,3-benzodioxol-4-yl)-1,4-dihydro-2,6-dimethyl-, 3-ethyl 5-methyl ester
  • 90729-41-2
  • C19H21NO6
Copyright 2019 © ChemicalBook. All rights reserved